GO:0110142 ubiquinone biosynthesis complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0110142 (ubiquinone biosynthesis complex) is a cellular_component term describing the multi-enzyme assembly that produces coenzyme Q (ubiquinone), a lipid-soluble electron carrier essential for mitochondrial respiration.
• In E. coli the complex comprises UbiE, UbiF, UbiG, UbiH, UbiI, UbiJ and UbiK; in eukaryotes it is located on the matrix face of the inner mitochondrial membrane and includes COQ3, COQ4, COQ5, COQ6, COQ7 and COQ9.
• The complex functions as a metabolon, channeling intermediates between sequential enzymes to improve catalytic efficiency and protect labile intermediates.
• CoQ deficiency or imbalance is linked to mitochondrial disease, neurodegeneration, cancer metabolic rewiring and liver metabolic disruption.
• Studying this complex requires integrated approaches: CRISPR knockout/knock-in models, proteomics, metabolomics, respirometry and structural biology.
• EDITGENE provides CRISPR cell model services (KO, point mutation, knock-in, overexpression, library screening, bioinformatics) to dissect ubiquinone biosynthesis complex gene function.
Description
The ubiquinone biosynthesis complex (GO:0110142) is a cellular_component term that defines the protein assembly responsible for producing ubiquinone, also known as coenzyme Q (CoQ). CoQ is a redox-active lipid that shuttles electrons from complexes I and II to complex III in the mitochondrial respiratory chain, and it also serves as a lipophilic antioxidant. Because CoQ is essential for oxidative phosphorylation, its biosynthesis must be tightly coordinated with mitochondrial function. The QuickGO definition specifies that this complex is composed of enzymes and accessory factors of the CoQ biosynthesis pathway; in E. coli it includes UbiE, UbiF, UbiG, UbiH, UbiI, UbiJ and UbiK, while in eukaryotes it is located on the matrix face of the inner mitochondrial membrane and includes COQ3, COQ4, COQ5, COQ6, COQ7 and COQ9. Researchers study this complex to understand how mitochondrial energy metabolism is maintained, how CoQ levels are regulated, and how defects contribute to human disease. The complex is often described as a metabolon or CoQ-synthome because its components physically associate to channel intermediates, enhancing pathway efficiency and preventing the accumulation of toxic intermediates. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the ubiquinone biosynthesis complex, its genes, mechanisms, disease relevance and experimental methods.
ubiquinone biosynthesis complex At A Glance
| GO ID | GO:0110142 |
|---|---|
| GO term | ubiquinone biosynthesis complex |
| Ontology | cellular_component |
| Synonym | complex Q; CoQ Biosynthetic Complex; CoQ metabolon; CoQ-synthome; Ubi complex |
| Major function | Catalyzes the biosynthesis of ubiquinone (coenzyme Q), a lipid-soluble electron carrier and antioxidant |
| E. coli components | UbiE, UbiF, UbiG, UbiH, UbiI, UbiJ, UbiK |
| Eukaryotic components | COQ3, COQ4, COQ5, COQ6, COQ7, COQ9 |
| Subcellular location (eukaryotes) | Matrix face of the inner mitochondrial membrane |
| Associated pathway | Ubiquinone biosynthesis (CoQ biosynthesis) |
What Is GO:0110142?
GO:0110142 (ubiquinone biosynthesis complex) is a protein complex composed of enzymes and accessory factors of the ubiquinone (CoQ) biosynthesis pathway. In E. coli, the complex is composed of seven proteins: UbiE, UbiF, UbiG, UbiH, UbiI, UbiJ and UbiK. In eukaryotes, the complex is located on the matrix face of the inner mitochondrial membrane and includes COQ3, COQ4, COQ5, COQ6, COQ7 and COQ9. Synonyms include complex Q, CoQ Biosynthetic Complex, CoQ metabolon, CoQ-synthome and Ubi complex.
Why Is ubiquinone biosynthesis complex Important in Cell Biology?
The ubiquinone biosynthesis complex is essential because it produces coenzyme Q, a molecule that is indispensable for mitochondrial electron transport, cellular antioxidant defense and numerous metabolic processes. Defects in CoQ biosynthesis cause primary CoQ deficiency, a clinically heterogeneous mitochondrial disorder that can affect the brain, muscle, kidney and other organs. Moreover, altered CoQ levels have been implicated in cancer metabolism, neurodegeneration and liver disease, making this complex a target for both mechanistic studies and therapeutic development. Understanding how the complex assembles and functions provides insight into mitochondrial biology and offers opportunities for pharmacological intervention.
• CoQ is a mandatory electron carrier in the mitochondrial respiratory chain, linking complexes I and II to complex III.
• The complex enables efficient substrate channeling, preventing accumulation of toxic intermediates.
• Mutations in COQ genes cause primary coenzyme Q deficiency, a rare but treatable mitochondrial disease.
• CoQ levels influence tumor growth, as ubiquinol oxidation is necessary for tumorigenesis in some models.
• CoQ imbalance can drive reverse electron transport and disrupt liver metabolism.
• The complex is a model for studying metabolon organization and membrane-associated enzyme assemblies.
• CoQ biosynthesis is regulated by mitochondrial retrograde signaling and nutrient status.
• The complex interacts with respiratory supercomplexes, influencing OXPHOS efficiency.
• Understanding the complex aids development of CoQ analogs and biosynthesis modulators.
• CRISPR-based models of COQ genes are valuable for dissecting gene function and disease mechanisms.
What Happens During ubiquinone biosynthesis complex?
Overview of ubiquinone biosynthesis
In simple terms: The complex acts like an assembly line that builds coenzyme Q step by step.
Ubiquinone biosynthesis is a multi-step pathway that converts precursor molecules into the fully functional CoQ lipid. In eukaryotes, the pathway begins with the formation of a polyisoprenoid tail and a quinone ring precursor, which are then modified by a series of enzymes including COQ3, COQ5, COQ6, COQ7 and COQ9. The enzymes of the ubiquinone biosynthesis complex are thought to physically associate, forming a metabolon that channels intermediates between active sites, thereby increasing pathway efficiency and protecting unstable intermediates. This organization is conserved from bacteria to humans, although the specific protein components differ.
Ring modification steps
In simple terms: Chemical groups are added to the ring of the CoQ molecule to make it functional.
The quinone ring undergoes a series of modifications including hydroxylation, methylation and decarboxylation. In E. coli, UbiG catalyzes O-methylation, UbiE catalyzes C-methylation, and UbiH and UbiF catalyze hydroxylation steps. In eukaryotes, COQ3 is an O-methyltransferase, COQ5 is a C-methyltransferase, COQ6 is a flavin-dependent monooxygenase, and COQ7 is a di-iron hydroxylase. These reactions are sequential and require the coordinated action of the complex to ensure correct order and substrate specificity.
Isoprenoid tail synthesis and attachment
In simple terms: A long lipid tail is built and attached to the ring to make CoQ soluble in membranes.
The polyisoprenoid tail of CoQ is synthesized by prenyltransferases and attached to the quinone ring precursor. In eukaryotes, COQ2 catalyzes the attachment of the polyisoprenoid tail to 4-hydroxybenzoate, forming the first membrane-bound intermediate. The length of the tail varies among species (e.g., CoQ10 in humans, CoQ9 in mice, CoQ6 in yeast), which influences the hydrophobic properties of the molecule.
Assembly and dynamics of the complex
In simple terms: The enzymes come together as a team, and their assembly is dynamic and regulated.
The ubiquinone biosynthesis complex is not a static structure; its assembly is dynamic and can be influenced by the availability of substrates and accessory factors. In yeast, Coq9 and Coq10 are required for the stability and function of the complex, and mutations in these genes affect CoQ levels. In mammals, COQ9 interacts with COQ7 and is thought to regulate its activity. Recent structural studies of respiratory supercomplexes have provided insights into how CoQ biosynthesis components may interact with the respiratory chain. The complex is also regulated by mitochondrial proteases and quality control pathways.
Key Genes Involved in GO:0110142 ubiquinone biosynthesis complex
The following genes and proteins are core components or accessory factors of the ubiquinone biosynthesis complex across model organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COQ2 | Prenyltransferase that attaches the isoprenoid tail to the quinone ring precursor | Mutations cause primary CoQ deficiency; target for metabolic studies |
| COQ3 | O-methyltransferase in the ring modification pathway | Essential for CoQ biosynthesis; knockout models show severe CoQ depletion |
| COQ4 | Accessory factor required for complex stability and function | Mutations linked to mitochondrial disease; potential scaffold protein |
| COQ5 | C-methyltransferase that modifies the quinone ring | Defects affect CoQ levels and respiratory chain function |
| COQ6 | Flavin-dependent monooxygenase involved in ring hydroxylation | Mutations cause steroid-resistant nephrotic syndrome and CoQ deficiency |
| COQ7 | Di-iron hydroxylase that catalyzes a key hydroxylation step | Regulated by mitochondrial signaling; knockout is lethal in mice |
| COQ9 | Lipid-binding protein that interacts with COQ7 and stabilizes the complex | Mutations cause severe neonatal mitochondrial disease |
| COQ10 | Accessory factor in yeast; human homolog COQ10A/B may regulate CoQ biosynthesis | Studied for its role in complex assembly and stability |
| UbiE | C-methyltransferase in E. coli CoQ biosynthesis | Bacterial model for studying enzyme mechanism |
| UbiF | Hydroxylase in E. coli CoQ biosynthesis | Contributes to ring modification steps |
| UbiG | O-methyltransferase in E. coli CoQ biosynthesis | Essential for CoQ production in bacteria |
| UbiH | Hydroxylase in E. coli CoQ biosynthesis | Involved in ring modification |
| UbiI | Monooxygenase in E. coli CoQ biosynthesis | Catalyzes a hydroxylation step |
| UbiJ | Accessory factor in E. coli CoQ biosynthesis | May stabilize the complex |
| UbiK | Accessory factor in E. coli CoQ biosynthesis | Potential regulatory role |
| PDSS1/PDSS2 | Prenyltransferases for the isoprenoid tail in eukaryotes | Mutations cause CoQ deficiency and nephropathy |
| ETFDH | Electron-transferring flavoprotein dehydrogenase; forms a metabolon with CoQ biosynthesis components | Supports OXPHOS efficiency in skeletal muscle |
How Is ubiquinone biosynthesis complex Regulated?
The ubiquinone biosynthesis complex is regulated at multiple levels. In yeast, the expression of COQ genes is controlled by the transcription factor Hap1 and other regulators in response to oxygen and carbon source. In mammals, CoQ biosynthesis is influenced by mitochondrial retrograde signaling, nutrient availability and hormonal cues. The complex interacts with the electron-transferring flavoprotein dehydrogenase (ETFDH) to form a metabolon that supports oxidative phosphorylation efficiency in skeletal muscle. Additionally, CoQ levels are affected by mitochondrial proteases and quality control pathways that degrade misfolded or unassembled complex components. Post-translational modifications of COQ proteins, such as phosphorylation, may also modulate their activity, although the details remain to be fully elucidated.
ubiquinone biosynthesis complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COQ2 | Primary CoQ deficiency, nephropathy | Knockout or point-mutation iPSC-derived podocytes |
| COQ6 | Steroid-resistant nephrotic syndrome | Kidney organoids with COQ6 mutations |
| COQ7 | Severe mitochondrial disease, neuropathy | Conditional knockout mouse models |
| COQ9 | Neonatal mitochondrial encephalopathy | Patient-derived fibroblasts and CRISPR-corrected isogenic lines |
| ETFDH | Skeletal muscle OXPHOS efficiency, CoQ homeostasis | Muscle-specific knockout or knock-in mice |
Primary coenzyme Q deficiency
Mutations in COQ genes (e.g., COQ2, COQ4, COQ6, COQ7, COQ9) cause primary coenzyme Q deficiency, a rare mitochondrial disorder with heterogeneous clinical presentations including encephalopathy, nephropathy, cardiomyopathy and ataxia. The severity depends on the specific mutation and the residual activity of the ubiquinone biosynthesis complex. Some patients respond to oral CoQ10 supplementation, highlighting the importance of early diagnosis.
Cancer metabolism
CoQ is necessary for mitochondrial electron transport and is required for tumor growth in certain cancer models. Mitochondrial ubiquinol oxidation is necessary for tumour growth, and inhibition of CoQ biosynthesis can suppress tumorigenesis. The ubiquinone biosynthesis complex is therefore a potential target for cancer therapy, particularly in cancers that rely on oxidative phosphorylation.
Liver metabolic disorders
CoQ imbalance drives reverse electron transport and disrupts liver metabolism, contributing to metabolic dysfunction. This suggests that the ubiquinone biosynthesis complex plays a role in maintaining hepatic metabolic homeostasis, and its dysregulation may be involved in fatty liver disease and insulin resistance.
Neurodegeneration
CoQ deficiency has been associated with neurodegenerative conditions such as cerebellar ataxia and Leigh syndrome. The ubiquinone biosynthesis complex is critical for neuronal survival due to the high energy demand of the brain, and its dysfunction can lead to progressive neurodegeneration.
From ubiquinone biosynthesis complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of COQ gene function impair mitochondrial respiration? | CRISPR knockout in HEK293 or HeLa cells followed by respirometry |
| How do patient mutations affect CoQ biosynthesis complex assembly? | Point-mutation knock-in via CRISPR in patient fibroblasts |
| Can tagged COQ proteins reveal complex composition? | Knock-in of FLAG/HA tags at endogenous loci followed by immunoprecipitation |
| Does overexpression of COQ genes rescue CoQ deficiency? | Lentiviral overexpression in COQ-mutant cells |
| What is the role of COQ9 in stabilizing COQ7? | Knockout and rescue with wild-type or mutant COQ9 |
| How does CoQ imbalance affect liver metabolism? | Liver-specific knockout mice and metabolomics |
How to Study the ubiquinone biosynthesis complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and pathway dependencies | Identify novel regulators of CoQ biosynthesis |
| AP-MS | Protein-protein interactions | Define complex composition and dynamics |
| LC-MS/MS lipidomics | CoQ and intermediate levels | Quantify pathway activity in cells and tissues |
| Seahorse respirometry | Oxygen consumption rate | Assess mitochondrial function upon gene perturbation |
| Blue native PAGE | Respiratory supercomplex assembly | Study complex I-III-IV organization |
| Immunofluorescence microscopy | Subcellular localization | Confirm mitochondrial matrix localization of COQ proteins |
| RNA-seq | Transcriptional changes | Evaluate compensatory responses to CoQ deficiency |
| CRISPR knock-in of tags | Endogenous protein tagging | Study protein localization and interactions |
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes required for CoQ biosynthesis and mitochondrial function. Libraries targeting COQ genes and related metabolic pathways enable systematic interrogation of the ubiquinone biosynthesis complex.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry (AP-MS) of tagged COQ proteins reveals the composition and dynamics of the ubiquinone biosynthesis complex. Proximity labeling approaches such as BioID can identify transient interactors.
Metabolomics and lipidomics
Quantitative metabolomics and lipidomics measure CoQ intermediates and final products, providing functional readouts of complex activity. LC-MS/MS methods are commonly used to detect CoQ10 and its precursors.
Respirometry and mitochondrial function assays
Seahorse extracellular flux analysis and high-resolution respirometry measure oxygen consumption rates to assess the impact of ubiquinone biosynthesis complex perturbations on oxidative phosphorylation.
How CRISPR Can Be Used to Study GO:0110142 ubiquinone biosynthesis complex
Knockout
CRISPR knockout of COQ genes (e.g., COQ2, COQ3, COQ4, COQ5, COQ6, COQ7, COQ9) in human cell lines such as HEK293 or HeLa results in reduced CoQ levels and impaired mitochondrial respiration. These models are valuable for studying the consequences of CoQ deficiency and for testing rescue strategies.
Point Mutation
Introducing patient-specific point mutations into COQ genes via CRISPR base editing or homology-directed repair allows researchers to study the functional impact of missense mutations on complex assembly and activity. Such models can reveal genotype-phenotype correlations and guide therapeutic approaches.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins at endogenous COQ loci enables visualization and affinity purification of the ubiquinone biosynthesis complex components. This approach preserves endogenous regulation and stoichiometry.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of COQ genes can rescue CoQ deficiency in mutant cells and provide insights into rate-limiting steps of the pathway. Overexpression models are also useful for structural studies requiring large amounts of protein.
How EDITGENE Supports ubiquinone biosynthesis complex Research
Researchers studying ubiquinone biosynthesis complex-related genes often need to determine whether a candidate gene is causally involved in CoQ production, mitochondrial function or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to accelerate this research, from gene knockout to precise point mutations and knock-in of tags or reporters.
Contact EDITGENE today to design your custom CRISPR model for ubiquinone biosynthesis complex research.
Frequently Asked Questions About ubiquinone biosynthesis complex
What is the ubiquinone biosynthesis complex?
The ubiquinone biosynthesis complex (GO:0110142) is a protein complex composed of enzymes and accessory factors that produce coenzyme Q (ubiquinone). In E. coli it includes UbiE, UbiF, UbiG, UbiH, UbiI, UbiJ and UbiK; in eukaryotes it is located on the matrix face of the inner mitochondrial membrane and includes COQ3, COQ4, COQ5, COQ6, COQ7 and COQ9.
What genes are involved in the ubiquinone biosynthesis complex?
Key genes include COQ2, COQ3, COQ4, COQ5, COQ6, COQ7, COQ9 and PDSS1/PDSS2 in eukaryotes, and ubiE, ubiF, ubiG, ubiH, ubiI, ubiJ, ubiK in E. coli.
Where is the ubiquinone biosynthesis complex located?
In eukaryotes, the complex is located on the matrix face of the inner mitochondrial membrane.
What is the function of the ubiquinone biosynthesis complex?
It catalyzes the biosynthesis of ubiquinone (coenzyme Q), a lipid-soluble electron carrier and antioxidant essential for mitochondrial respiration.
What diseases are associated with defects in the ubiquinone biosynthesis complex?
Mutations in COQ genes cause primary coenzyme Q deficiency, which can lead to encephalopathy, nephropathy, cardiomyopathy and ataxia. CoQ imbalance has also been implicated in cancer and liver metabolic disorders.
How is the ubiquinone biosynthesis complex regulated?
It is regulated by transcriptional control, mitochondrial retrograde signaling, nutrient availability and interactions with proteins such as ETFDH.
What methods are used to study the ubiquinone biosynthesis complex?
Common methods include CRISPR knockout/knock-in, proteomics, lipidomics, respirometry, blue native PAGE and immunofluorescence microscopy.
Can CRISPR be used to model CoQ deficiency?
Yes, CRISPR knockout or point mutation of COQ genes in cell lines and iPSCs can model CoQ deficiency and help study disease mechanisms.
What is the CoQ metabolon?
The CoQ metabolon, also called the CoQ-synthome, is a dynamic assembly of CoQ biosynthesis enzymes that channel intermediates for efficient production of coenzyme Q.
Why is coenzyme Q important for cancer?
CoQ is required for mitochondrial electron transport and ubiquinol oxidation is necessary for tumour growth in some models, making the pathway a potential cancer target.
Conclusion
The ubiquinone biosynthesis complex (GO:0110142) is a central component of mitochondrial metabolism, responsible for producing coenzyme Q, a molecule essential for respiration and antioxidant defense. Its dysfunction leads to a spectrum of human diseases, from primary CoQ deficiency to cancer and metabolic disorders. Advances in CRISPR technology and multi-omics approaches are enabling detailed dissection of the complex's assembly, regulation and pathobiology. Continued research will likely uncover new therapeutic opportunities targeting CoQ biosynthesis.
References
- 1. Hirst J. 2013. Mitochondrial complex I.. Annu Rev Biochem 82:551-75 PMID: 23527692
- 2. Guerra RM et al.. 2023. Coenzyme Q biochemistry and biosynthesis.. Trends Biochem Sci 48(5):463-476 PMID: 36702698
- 3. Wang Y et al.. 2024. Understanding coenzyme Q.. Physiol Rev 104(4):1533-1610 PMID: 38722242
- 4. Zheng W et al.. 2024. High-resolution in situ structures of mammalian respiratory supercomplexes.. Nature 631(8019):232-239 PMID: 38811722
- 5. Goncalves RLS et al.. 2025. CoQ imbalance drives reverse electron transport to disrupt liver metabolism.. Nature 643(8073):1057-1065 PMID: 40437093
- 6. Martínez-Reyes I et al.. 2020. Mitochondrial ubiquinol oxidation is necessary for tumour growth.. Nature 585(7824):288-292 PMID: 32641834
- 7. Herrero Martín JC et al.. 2024. An ETFDH-driven metabolon supports OXPHOS efficiency in skeletal muscle by regulating coenzyme Q homeostasis.. Nat Metab 6(2):209-225 PMID: 38243131
- 8. González-Mariscal I et al.. 2014. Regulation of coenzyme Q biosynthesis in yeast: a new complex in the block.. IUBMB Life 66(2):63-70 PMID: 24470391
